Skip to main content
. 2007 Apr;3(2):203–210. doi: 10.2147/vhrm.2007.3.2.203

Figure 3.

Figure 3

Fasting plasma glucose (FPG, left panel) and postprandial glucose (PPG, right panel) in sitagliptin (100 mg/d) monotherapy over 24 weeks in formerly drug-naïve patients with type 2 diabetes. From data of Aschner et al (2006a).